BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, April 25, 2025
See today's BioWorld Asia
See today's BioWorld
Home
» SK Group prepares IPO for subsidiary SK Biopharmaceuticals
To read the full story,
subscribe
or
sign in
.
SK Group prepares IPO for subsidiary SK Biopharmaceuticals
May 26, 2020
By
Gina Lee
HONG KONG – South Korean conglomerate SK Group is preparing to list its subsidiary, SK Biopharmaceuticals Co. Ltd., on the Stock Market Division of the Korea Exchange.
BioWorld
BioWorld Asia
Financings
Cancer
Neurology/psychiatric
IPO
Asia-Pacific
